Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Histogen Inc (HSTO)

Histogen Inc (HSTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 918
  • Shares Outstanding, K 4,270
  • Annual Sales, $ 3,770 K
  • Annual Income, $ -10,620 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.19
  • Price/Sales 100.32
  • Price/Cash Flow N/A
  • Price/Book 0.21
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.81
  • Most Recent Earnings N/A on 08/10/23
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2100 +2.38%
on 11/11/24
0.3000 -28.33%
on 10/18/24
-0.0025 (-1.15%)
since 10/03/24
3-Month
0.2100 +2.38%
on 11/11/24
0.3000 -28.33%
on 10/18/24
-0.0050 (-2.27%)
since 08/14/24
52-Week
0.0501 +329.14%
on 04/19/24
0.5500 -60.91%
on 04/09/24
-0.1101 (-33.87%)
since 11/14/23

Most Recent Stories

More News
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.2150 (unch)
Histogen: Q1 Earnings Snapshot

Histogen: Q1 Earnings Snapshot

HSTO : 0.2150 (unch)
Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration

Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.

HSTO : 0.2150 (unch)
Histogen: Q3 Earnings Snapshot

Histogen: Q3 Earnings Snapshot

HSTO : 0.2150 (unch)
CEL-SCI Appoints Dr. Gail Naughton to Its Board of Directors

CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Dr. Gail K. Naughton to its Board of Directors.

CVM : 0.7299 (-4.60%)
ATIS : 0.1000 (-47.37%)
HSTO : 0.2150 (unch)
TXMD : 1.1100 (+1.83%)
Histogen Announces Closing of $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen Announces 1-for-20 Reverse Stock Split

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Histogen to Present at the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative...

HSTO : 0.2150 (unch)
Paracrine Announces Appointment of Biotech Veteran David Crean, Ph.D. to the Board of Directors

Paracrine, Inc., a company developing its novel cell therapy platform in late-stage clinical trials in advanced wound care, announced today the appointment of David Crean, Ph.D. as an independent Director...

HSTO : 0.2150 (unch)

Business Summary

Histogen Inc. is a regenerative medicine company. It engages in developing patented technologies which replace and regenerates tissues in the body. The company's technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing...

See More

Key Turning Points

3rd Resistance Point 0.2150
2nd Resistance Point 0.2150
1st Resistance Point 0.2150
Last Price 0.2150
1st Support Level 0.2150
2nd Support Level 0.2150
3rd Support Level 0.2150

See More

52-Week High 0.5500
Fibonacci 61.8% 0.3590
Fibonacci 50% 0.3001
Fibonacci 38.2% 0.2411
Last Price 0.2150
52-Week Low 0.0501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar